Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

iBio, Inc. Common Stock (IBIO)

Compare
3.9100
-0.1100
(-2.74%)
At close: April 1 at 4:00:02 PM EDT
4.0684
+0.16
+(4.05%)
After hours: April 1 at 7:42:21 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
375
225
--
1,884
2,371
Cost of Revenue
--
--
--
216
1,462
Gross Profit
--
--
--
2,167
909
Operating Expense
15,935
16,859
29,343
31,581
32,020
Operating Income
-15,560
-16,634
-29,343
-29,697
-31,111
Net Non Operating Interest Income Expense
326
191
130
177
-2,314
Other Income Expense
--
1,000
-98
7
10,212
Pretax Income
-14,234
-15,443
-29,311
-29,513
-23,213
Net Income Common Stockholders
-19,303
-24,907
-65,010
-50,391
-23,467
Diluted NI Available to Com Stockholders
-19,303
-24,907
-65,010
-50,391
-23,467
Basic EPS
1.71
-6.50
-106.19
-115.60
-60.00
Diluted EPS
1.71
-6.50
-106.19
-115.60
-60.00
Basic Average Shares
7,508.5000
3,831
612
436.0500
391.2400
Diluted Average Shares
7,508.5000
3,831
612
436.0500
391.2400
Total Operating Income as Reported
-15,560
-16,634
-29,343
-29,697
-31,111
Total Expenses
15,935
16,859
29,343
31,581
33,482
Net Income from Continuing & Discontinued Operation
-19,303
-24,907
-65,010
-50,303
-23,207
Normalized Income
-15,234
-16,443
-29,213
-29,512
-33,407
Interest Income
552
363
213
177
140
Interest Expense
226
172
83
--
2,454
Net Interest Income
326
191
130
177
-2,314
EBIT
-14,008
-15,271
-29,228
-29,513
-20,759
EBITDA
-12,836
-14,021
-27,848
-25,722
-18,345
Reconciled Cost of Revenue
--
--
--
216
1,462
Reconciled Depreciation
1,172
1,250
1,380
3,791
2,414
Net Income from Continuing Operation Net Minority Interest
-14,234
-15,443
-29,311
-29,512
-23,207
Total Unusual Items Excluding Goodwill
1,000
1,000
-98
607
10,200
Total Unusual Items
1,000
1,000
-98
607
10,200
Normalized EBITDA
-13,836
-15,021
-27,750
-25,722
-28,545
6/30/2021 - 8/19/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GLTO Galecto, Inc.
2.8200
-9.03%
 
NTHI NeOnc Technologies Holdings, Inc. Common Stock
11.26
-10.42%
 
QLGN Qualigen Therapeutics, Inc.
3.4900
-4.12%
 
CRVO CervoMed Inc.
9.98
+9.07%
 
LQDA Liquidia Corporation
14.51
-1.63%
 
CANF Can-Fite BioPharma Ltd.
1.4000
-5.41%
 
JAGX Jaguar Health, Inc.
4.7600
+0.21%
 
VXRT Vaxart, Inc.
0.3725
-8.48%
 
IBO Impact BioMedical Inc.
0.8200
-5.75%
 
CMMB Chemomab Therapeutics Ltd.
1.0400
-4.59%